Hester Biosciences confirms not a Large Corporate; long-term borrowings at Rs 12.78 cr

HESTERBIO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+1.7%1-day move

₹1405.00

prior close

₹1419.50

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.3+0.0+0.4+0.0+1.7+0.7+1.7+3.9+2.3+6.0+19.9+18.5+39.0+54.5

Up moveDown movePending

AI summary

Hester Biosciences filed a mandatory SEBI disclosure (under the 2018 Large Corporate framework) confirming it does NOT qualify as a Large Corporate. Its outstanding long-term borrowings (excluding ECB) stood at just Rs 12.78 crore as on 31 March 2026, well below the Rs 100 crore threshold needed for Large Corporate status. The company also disclosed its credit rating of CARE BBB+ (Stable) from CARE Ratings. No incremental borrowing or fine obligation arises from this filing.

Likely market impact

Routine compliance filing with no material impact on shareholders or stock price; simply confirms small borrowings and exemption from Large Corporate rules.